Skip to main content
Back
Watch Compare

SBC Medical Group Holdings Inc

Data quality: 100%
Also listed as SBCWW Nasdaq
SBC
Nasdaq Services Health Services
$4.12
▼ $0.22 (-5.07%)
Mkt Cap: 422.62 M
Price
$4.12
Mkt Cap
422.62 M
Day Range
$4.08 — $4.30
52-Week Range
$2.97 — $5.75
Volume
109,378
Open $4.30
50D / 200D Avg
$4.12
0.08% above
50D / 200D Avg
$4.18
1.46% below

Quick Summary

Key Takeaways

ROE of 20.70% indicates high profitability
Net margin of 29.37% shows strong profitability
Debt/Equity of 0.09 — conservative balance sheet
Generating 23.27 M in free cash flow
P/E of 8.29 — trading at a low valuation
Capital efficient — spends only 0.81% of revenue on capex

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)-15.48%
Earnings (1Y)9.38%
FCF Growth (3Y)N/A

Quality

Return on Equity
20.70%
Above sector avg (-15.95%)
ROIC15.80%
Net Margin29.37%
Op. Margin38.87%

Safety

Debt / Equity
0.09
Below sector avg (0.39)
Current Ratio5.10
Interest Coverage455.26

Valuation

PE (TTM)
8.29
Above sector avg (-1.17)
P/B Ratio1.70
EV/EBITDA4.51
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (502 peers)
Metric Stock Sector Median
P/E 8.3 -1.2
P/B 1.7 1.4
ROE % 20.7 -16.0
Net Margin % 29.4 -19.4
Rev Growth 5Y % — 4.0
D/E 0.1 0.4

ETFs Holding This Stock

INDE logo INDE Matthews India Active ETF INDE
0.60% weight
AVEE logo AVEE Avantis Emerging Markets Small Cap Equity ETF
0.01% weight
AVXC logo AVXC Avantis Emerging Markets ex-China Equity ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -15.48% Revenue Growth (3Y) N/A
Earnings Growth (1Y) 9.38% Earnings Growth (3Y) 860.36%
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 173.61 M Net Income (TTM) 50.99 M
ROE 20.70% ROA 16.02%
Gross Margin 73.32% Operating Margin 38.87%
Net Margin 29.37% Free Cash Flow (TTM) 23.27 M
ROIC 15.80% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.09 Current Ratio 5.10
Interest Coverage 455.26 Asset Turnover 0.55
Working Capital 182.62 M Tangible Book Value 219.76 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 8.29 Forward P/E N/A
P/B Ratio 1.70 P/S Ratio 2.43
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 4.51 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 5.51%
Market Cap 422.62 M Enterprise Value 316.31 M
Per Share
EPS (Diluted TTM) 0.50 Revenue / Share 1.69
FCF / Share 0.23 OCF / Share 0.24
EPS CAGR (1Y) 4.17% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.81% FCF Conversion 45.64%
SBC-Adj. FCF 23.27 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2022 FY2023
Revenue 173.61 M 205.42 M — —
Net Income 50.99 M 46.61 M 552,813.0 339,767.0
EPS (Diluted) 0.50 0.48 — —
Gross Profit 127.28 M 156.05 M — —
Operating Income 67.49 M 70.30 M -543,695.0 -1.77 M
EBITDA — — — —
R&D Expenses — — — —
SG&A Expenses 59.80 M 57.67 M — —
D&A 2.68 M 3.80 M — —
Interest Expense 148,238.0 28,300.0 — —
Income Tax 31.02 M 26.77 M 248,508.0 528,809.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2022 FY2023
Total Assets 380.45 M 266.08 M 119.94 M 21.25 M
Total Liabilities 117.14 M 71.06 M 4.59 M 6.63 M
Shareholders' Equity 248.28 M 195.11 M -3.36 M -5.99 M
Total Debt 42.83 M 6.60 M — —
Cash & Equivalents 163.77 M 125.04 M 485,564.0 —
Current Assets 231.22 M 184.45 M 722,189.0 394,543.0
Current Liabilities 61.12 M 61.19 M 566,012.0 2.61 M